The centre will be located within the Hollywood Medical Centre on the campus of Ramsay Health Care’s flagship Hollywood Private Hospital, the largest private hospital in the country. This convenient location helps meet the growing need for molecular imaging and therapy services, making it easier for more people across the state to receive the care they need.
Icon’s Clinical Director of Molecular Imaging and Nuclear Oncology, Nuclear Medicine Physician and founder of Theranostics Australia, Dr Nat Lenzo said this centre will increase access to cutting-edge treatments.
“This comprehensive centre represents the future of personalised cancer care and marks a major step forward in improving access to cutting-edge theranostics, which offer real hope for people with advanced and metastatic cancers,” said Dr Lenzo.
“By offering patients access to a full suite of imaging and precision medicine treatments under one roof we’re improving the patient experience and ensuring we can better support people and their families through a difficult time without the need to travel far distances.”
Equipped with Siemens Healthineers’ Biograph Trinion PET-CT, a first in WA, and Symbia Pro.specta X3 SPECT/CT, the facility offers highly advanced imaging technology that support diagnosis, staging and treatment of cancers including prostate cancer and neuroendocrine tumours, as well as new and developing uses in neurology and cardiology.
Theranostics is a growing area of medicine that combines advanced diagnostic imaging with highly targeted treatment. It identifies a person’s unique cancer cells and delivers personalised targeted therapy to the cancer and aims to slow the growth and spread of cancer, relieve symptoms and maintain or improve quality of life. Theranostics may be considered for people with advanced cancer, when standard treatment options are unsuitable or no longer effective and symptoms are affecting quality of life.
